OKYO
OKYO
NASDAQ · Biotechnology

Okyo Pharma Ltd

$1.92
+0.02 (+1.05%)
As of Feb 8, 2:15 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 9.01M 9.02M 8.76M
Net Income -596,230 -528,269 -565,775
EPS
Profit Margin -6.6% -5.9% -6.5%
Rev Growth +12.0% +12.6% +22.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 28.04M 27.36M 27.28M
Total Equity 36.63M 39.85M 39.13M
D/E Ratio 0.77 0.69 0.70
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -746,119 -716,524 -642,558
Free Cash Flow -600,890 -503,274 -433,552